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Objective. The purpose of this study was to evaluate the presence of myofibroblasts, frequently associated with a more
aggressive neoplastic behavior, in oral tongue squamous cell carcinoma (TSCC) of young patients and to compare with the
distribution observed in older patients.
Study Design. Tumor samples from 29 patients younger than 40 years old affected by TSCC were retrieved and investigated for
the presence of stromal myofibroblasts by immunohistochemical reactions against a smooth muscle actin, and the results
obtained were compared to TSCC cases affecting older patients.
Results. No positive reaction could be found in the stromal areas devoid of neoplastic tissue, whereas myofibroblasts were
present in 58.6% of the lesions in young patients and in 75.9% of the older ones. No significant difference was found when
comparing the invasive front and the overall stroma of both groups, and no correlation could be obtained with stromal a
smooth muscle actin expression, higher tumor grades or clinical stage (P > .05).
Conclusion. There was no significant difference between the presence of stromal myofibroblasts of TSCC affecting young and
old individuals. (Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118:483-489)Oral cancer is a health problem worldwide, accounting
for approximately 25 to 30 % of all malignant tumors in
developing countries and ranking among the top three
types of cancer in areas of the Asiatic continent, mostly
because of the increased use of products containing
tobacco.1-4 Oral squamous cell carcinoma (OSCC) is
the most common subtype of oral cancer, responsible
for 95% of oral malignant tumors.5,6 Although it is
frequently diagnosed in the adult population in the ﬁfth
decade of life, OSCC incidence in young patients (age
<40) has been shown to be increasing in different parts
of the globe, but the exact mechanisms and the new
possible etiologic factors involved in its onset in young
people remain obscure.7 Moreover, the biological
behavior of OSCC affecting young patients has been aThe authors state that they have no potential conﬂict of interest that
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a more aggressive clinical course compared to lesions
in older individuals,8-11 whereas others found no sig-
niﬁcant difference.12-14
More recent studies concluded that youngpatientswith
tongue SCC represent a distinct clinical and biological
entity because of an increased number of nonsmoking
and nondrinking patients among this particular group of
oral cancer patients, and a decreased ratio of male-to-
female individuals.15,16 In addition, increased genomic
instability and other underlying genetic features that
distinguish lesions in young persons from older patients
with tongue SCC have been recently reported.17,18
Myoﬁbroblasts were ﬁrst identiﬁed in granulation
tissue and wounds.1,19,20 They exhibit an intermediary
phenotype between ﬁbroblasts and smooth muscle
cells, being characterized by the expression of a smooth
muscle actin (a-SMA).5 In the last few years, myoﬁ-
broblasts have been found to be a major component in
the stroma of different human malignancies and are
now believed to play an important role in the epithelial/Statement of Clinical Relevance
No signiﬁcant difference exist between the stromal
myoﬁbroblastic component of tongue squamous cell
carcinoma affecting young and old individuals and
myoﬁbroblastsmaynot be responsible for any different
behavior that may exist between both groups.
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Fig. 1. Histopathological distribution of overall stroma and invasive front area of TSCC used in the present study. A and B,
Microscopic image under low magniﬁcation illustrating the invasive tumor front (bottom) and stromal (top) region of the tumor
(H&E; 100). C, Higher magniﬁcation of the overall stromal component of the tumors (H&E; 200). D, Higher magniﬁcation of
the invasive front of the tumor (H&E; 200; TSCC, tongue squamous cell carcinoma).
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formation, growth, and progression of epithelial tu-
mors.1,19 It has been shown that through an exchange of
cytokines, extracellular matrix proteins, and enzymes
between cancer and stromal cells, myoﬁbroblasts would
also promote neoplastic invasion and migration, thereby
being implicated in the aggressive potential of
numerous epithelial malignancies.21-23
Recent studies have shown that myoﬁbroblasts
stimulate OSCC growth, proliferation, and invasive-
ness, and that malignant cells may directly induce
myoﬁbroblast transdifferentiation, illustrating the mo-
lecular cross talk between both components in the oral
carcinogenesis process.19,23-25 Hence, because of the
apparent increased aggressiveness of OSCC in young
patients suggested in the literature and the recently
described association of myoﬁbroblasts with the pro-
gression of numerous human cancers, the authors in this
study evaluated the presence of myoﬁbroblasts in the
stroma of SCC affecting the lateral border of the oral/
mobile tongue of patients younger than 40 years old,
with the purpose of testing the hypothesis that such a
stromal component would be differently distributed
between both groups due to their speculated different
biological behavior.
METHODS
Tissue samples
The study sample consisted of formalin-ﬁxed, parafﬁn-
embedded TSCCs (squamous cell carcinoma affecting
the lateral border of the oral/mobile tongue) retrieved
from four different oral pathology centers at the Uni-
versity of Campinas (Piracicaba Dental School, Brazil),Universidade Estadual Paulista (Araçatuba Dental
School, Brazil), Centro Clínico de Cabeza y Cuello
(Guatemala) and the University of Shefﬁeld (School of
Clinical Dentistry, UK) in a 20-year period from 1988
to 2008. Those patients previously treated by surgery,
radiotherapy, or chemotherapy, and those cases with
insufﬁcient tissue for analysis and a lack of clinical
information, were excluded. The international approach
was undertaken because of the low incidence of TSCC
in young patients and to enable a sufﬁcient number of
tongue lesions to be collected.
Demographic data (age and gender), social habits
(tobacco and alcohol consumption), and stage of
disease at diagnosis, according to the 2002 Union for
International Cancer Control (UICC) TNM classiﬁ-
cation of malignant tumors, were collected from the
patients’ clinical charts. Original H&E-stained slides
were reviewed by two oral pathologists, and tumors
were classiﬁed as well-, moderately, or poorly
differentiated. The results were compared with those
of a control group of patients older than 40 years
selected from the archives of Piracicaba Dental
School and matched by tumor site, histopathologic
grade, and clinical stage of disease at diagnosis.
This study was approved by the Ethics Committee
for Human Studies, Piracicaba Dental School, and the
South Shefﬁeld Research Ethics Committee.
Immunohistochemistry
Immunohistochemical analyses were performed using
the streptavidin-biotin peroxidase complex method
as previously described.26 Brieﬂy, the reactions
were conducted on 3 mm sections of the original
Table I. Clinical features of the young and old patients studied in the current investigation
No.
Young patients (age <40 y) Old patients (age  40 y)
Stage Sex Age Tobacco Alcohol Stage Sex Age Tobacco Alcohol
1 I/II F 36 - - I/II F 53 þ þ
2 I/II F 21 - - I/II F 71 þ þ
3 I/II M 28 - þ I/II F 69 þ þ
4 I/II M 39 þ þ I/II F 71 þ -
5 I/II M 34 þ þ I/II F 71 - -
6 I/II M 31 - þ I/II F 57 þ -
7 I/II M 37 þ - I/II M 57 þ þ
8 I/II M 37 þ þ I/II M 62 þ þ
9 I/II M 35 þ þ I/II F 41 - -
10 I/II M 36 - þ I/II F 74 þ þ
11 I/II F 40 - - I/II M 66 - -
12 I/II M 26 - - I/II M 58 þ þ
13 I/II M 25 - þ I/II M 77 NS NS
14 I/II F 33 - þ I/II F 67 - -
15 I/II F 35 - - I/II M 53 þ þ
16 III/IV M 36 þ - III/IV F 52 þ þ
17 III/IV F 31 þ - III/IV F 67 þ þ
18 III/IV F 29 - - III/IV F 57 þ þ
19 III/IV M 40 þ þ III/IV F 56 þ þ
20 III/IV M 31 - þ III/IV F 68 þ þ
21 III/IV M 36 þ þ III/IV F 58 þ þ
22 III/IV M 38 þ þ III/IV F 67 þ -
23 III/IV M 38 þ þ III/IV F 54 þ þ
24 III/IV M 40 - þ III/IV F 74 þ þ
25 III/IV M 16 þ - III/IV F 56 þ þ
26 III/IV F 36 - þ III/IV F 50 þ þ
27 III/IV F 36 þ - III/IV F 60 þ þ
28 III/IV M 26 þ þ III/IV F 73 þ -
29 III/IV M 29 þ þ III/IV F 57 þ þ
NS, not speciﬁed; (þ), positive; (-), negative; F, female; M, male.
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dewaxed with xylene and then hydrated in an ethanol
series. Antigen retrieval was carried out, and endogenous
peroxidase activity was blocked using 10% hydrogen
peroxide in ﬁve baths, each of 5 minutes. After washing
in PBS buffer (pH 7.4), slides were incubated overnight
with the primary antibody: Monoclonal mouse anti-a-
SMA, diluted 1:200 (Dako Corp., Carpenteria, CA). All
slides were subsequently exposed to avidin-biotin com-
plex and horseradish peroxidase reagents (LSAB
Kit -DakoCytomation, Dako, Glostrup, Denmark) and
diaminobenzidin tetrahydrochloride (DAB, Sigma, St.
Louis, MO), and subsequently counterstained with Car-
azzi’s hematoxylin. Normal vessels were used as internal
positive control, whereas the negative control was ob-
tained by omitting the primary speciﬁc antibody. The
presence of a-SMA positive cells was classiﬁed as
negative (0) (0% to 5% of positivity in the area
analyzed), weak (1) (6% to 50% of positivity in the area
analyzed) or strong (2) (>50% of positivity in the area
analyzed) in two different areas of each case: The stroma
within the tumor, considered as the overall area for the
purposes of this study, and the tumor front, which
represented the band of tissue between the invasivetumor front and adjacent normal connective tissue
(Figure 1), in a blinded analysis performed by three of
the authors.23Statistical analysis
Correlations between the presence of myoﬁbroblasts
and clinicopathological parameters were performed by
Fisher’s exact test at 5% signiﬁcance GraphPad Prism
version 5.0 (San Diego, CA).RESULTS
There were 29 young patients with TSCC (Table I). The
mean age of these patients at the time of the biopsy was
32.93 years (range 16-40), with a male preponderance
(male-to-female ratio of 2.2:1). A proportion of 51.7%
of the patients were smokers and 62.1% were alcohol
users. The matched group of 29 older patients presented
a mean age of 61.93 years (range 41-77) and had a
female preponderance with a male-to-female ratio of
1:3.2. Most of the older patients reported both tobacco
(82.8%) and alcohol consumption (69.1%). Both
groups were also matched according to UICC clinical
staging, comprising 14 patients classiﬁed as stage I/II
Table II. Intensity of aSMA staining in each case according to histopathological grade of tumors
No.
Young patients (age <40 y) Old patients (age  40 y)
Histologic grade Front Overall Stroma Histologic grade Front Overall Stroma
1 Well 0 0 Well 1 1
2 Well 1 1 Well 0 2
3 Well 1 1 Well 1 1
4 Well 0 0 Well 0 0
5 Well 1 2 Well 0 0
6 Well 0 0 Well 1 2
7 Well 1 1 Well 1 2
8 Well 0 1 Well 1 2
9 Well 0 0 Well 2 1
10 Well 0 0 Well 2 2
11 Well 0 0 Well 2 1
12 Well 0 0 Well 1 1
13 Poor 2 2 Poor 1 2
14 Poor 1 2 Poor 1 0
15 Moderate 2 0 Moderate 2 1
16 Moderate 0 0 Moderate 2 2
17 Moderate 0 0 Moderate 0 0
18 Moderate 0 1 Moderate 0 1
19 Moderate 0 1 Moderate 2 0
20 Moderate 1 1 Moderate 0 0
21 Moderate 2 2 Moderate 2 0
22 Moderate 0 0 Moderate 0 0
23 Moderate 2 2 Moderate 0 0
24 Moderate 0 0 Moderate 0 0
25 Moderate 2 2 Moderate 0 1
26 Moderate 1 1 Moderate 0 1
27 Moderate 2 2 Moderate 1 1
28 Moderate 0 1 Moderate 2 2
29 Moderate 2 2 Moderate 1 1
0, negative; 1, weak; 2, strong.
ORAL AND MAXILLOFACIAL PATHOLOGY OOOO
486 Fonseca et al. October 2014and 15 patients in stages III/IV in each group, and ac-
cording to histopathologic grade (12 well-, 15 moder-
ately, and 2 poorly differentiated cases; Table II).
Immunohistochemical positivity for aSMA was seen
in 67.2% (n ¼ 39) of the tumors studied. It was noted
that in the stromal area devoid of neoplastic tissue, no
positive reaction could be found. With regard to TSCC
cases affecting young patients, aSMA positivity was
found in 58.6% of the cases (n ¼ 17). Among these,
there was a strong reaction in the advancing front area
in 6 cases, a weak reaction in another 7 cases, and a
negative reaction in the remaining 4 cases, whereas
reactivity was strong in the stromal compartment in 8
cases, but proved to be weak in the other 9 cases. In the
lesions affecting older individuals, positivity was seen
in 75.9% of the sample studied (n ¼ 22). Strong
staining was present in the front compartment in 8
cases, weak staining in 10 cases, and negative staining
in the remaining 4 cases. Stromal positivity was strong
in 8 cases, weak in 11 cases, and negative in 3 cases.
Comparing the expression of aSMA in young and adult
patients in both front (Figure 2) and stromal (Figure 3)
areas, no statistically signiﬁcant difference could be
obtained (P > .05).No signiﬁcant difference could be seen by comparing
the presence of myoﬁbroblasts between cases classiﬁed
as stage I/II and stage III/IV (P > .05). Similarly,
aSMA positivity did not signiﬁcantly correlate with the
histopathologic grade of the tumors (P > .05).
DISCUSSION
OSCC is regarded as a disease of the elderly, affecting
patients over 45 years of age; however, an increased
number of young patients diagnosed with this condition
has been reported in recent decades.2,27 Although the
incidence of OSCC affecting young adults usually
ranges from 2% to 6% in most specialized services
worldwide,7,12,14,28 a higher incidence has been
recently described in parts of the USA,29 western
Europe,12 Latin America,6,7 and Asia.15 Related to this
variability in the epidemiology of OSCC affecting
young patients are uncertainties related to their bio-
logical and clinical behavior. Cases in young patients
have been considered to represent a more aggressive
disease than those diagnosed in older patients, and may
also not be associated with tobacco use and alcohol
intake, suggesting that alternative etiologic factors may
be involved with its onset.7,13,30 However, recent
Fig. 2. aSMA immunohistochemical expression in the front area of TSCC affecting patients older and younger than 40 years of
age. A, Strong reactivity for aSMA in the invasive front areas of the tumor (streptavidin-biotin; 50). B, Higher magniﬁcation
detailing the strong positivity of aSMA in the invasive front region (streptavidin-biotin; 100). C, Negative/weak reactivity for
aSMA in the invasive front areas of the tumor (streptavidin-biotin; 50). D, Higher magniﬁcation detailing the negative/weak
positivity of aSMA in the invasive front region (streptavidin-biotin; 100; TSCC, tongue squamous cell carcinoma; aSMA, a
smooth muscle actin).
Fig. 3. aSMA immunohistochemical expression in the stromal area of TSCCaffecting patients older and younger than 40 years of age.
A, Strong reactivity for aSMA in the overall stromal region of the tumor (streptavidin-biotin; 50).B, Higher magniﬁcation detailing
the strong positivity of aSMA in the neoplastic stroma (streptavidin-biotin; 100). C, Negative/weak reactivity for aSMA in the
overall stromal areas of the tumor (streptavidin-biotin; 50).D, Higher magniﬁcation detailing the negative/weak positivity of aSMA
in the stromal region (streptavidin-biotin; 100; TSCC, tongue squamous cell carcinoma; aSMA, a smooth muscle actin).
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the prognosis, survival, and treatment response of
young patients afﬂicted by OSCC compared with older
ones, and molecular evaluation of the lesions has failed
to show signiﬁcant differences, again suggesting that no
relevant difference exists.10,27,31,32Although activation of the host stroma has been
considered an important early step for tumorigenesis in
different human cancers,20 studies investigating the
stromal constituents of OSCC affecting young in-
dividuals and their relevance for the biological behavior
of these tumors are very scarce, and speciﬁc studies of
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ducted. Therefore, in the present manuscript, the au-
thors evaluated the presence of myoﬁbroblasts in the
invasive front area of the neoplastic islands and in the
overall stromal compartment of TSCC of young pa-
tients with the purpose of better understanding the
biological features of this uncommon clinical presen-
tation of OSCC. The results obtained revealed that there
was no statistically signiﬁcant difference between the
presence of myoﬁbroblasts in young patients and in
older individuals, either in the advancing front of the
tumor or in the overall stroma of the neoplasms, that
could suggest a more aggressive behavior. This was
further supported by the lack of association between
myoﬁbroblasts and both the histopathologic grade of
tumors and the clinical stage of patients. This is in
accordance with other studies from our group, which
failed to ﬁnd differences in the histopathologic proﬁle
of OSCC from young and old patients.7,17
Determining the best cut-off value between young
and old patients affected by OSCC has been a debatable
ﬁeld in literature. Although several authors claimed 45
years as the most appropriate age, providing larger
samples of younger patients, most of the recent studies
have used 40 years as the cut-off value, and therefore
we opted for this value to better compare the obtained
results with those recently described in literature.6-9
However, in a 2002 national-based study, Funk et al.33
described signiﬁcant differences in the biological
behavior of patients distributed in three different cate-
gories, those younger than 33 years, between 35 and 65
years, and older than 66 years. Although we observed a
higher myoﬁbroblast density in older patients (data not
shown), once again no statistical signiﬁcance could be
reached by categorizing our patients in line with this
classiﬁcation.
Several studies have shown that the microenviron-
ment of neoplastic tissues plays an active role in tumor
progression, and that to the conversion of normal
epithelial tissue to dysplastic epithelium to carcinoma,
the stroma would also change to an activated state
where ﬁbroblasts, one of the most important constitu-
ents of this compartment, are transdifferentiated to
active myoﬁbroblasts, representing a crucial event in
human carcinogenesis.1,20,34 This change in the state of
myoﬁbroblasts seems to be mediated by growth factors
and cytokines expressed by tumor cells, especially
transforming growth factor beta (TGF-b), whereas
myoﬁbroblasts would in turn secrete numerous growth
factors and inﬂammatory mediators that stimulate
epithelial neoplastic cell proliferation.20,25,34 Hence,
various studies have proved the importance of stromal
elements in tumoral development, growth, invasion,
and aggressiveness, illustrating myoﬁbroblasts as can-
cer-induced host cells.35Our group and other authors previously found that
myoﬁbroblasts would also be present in the stroma of
OSCC, signiﬁcantly correlating to the rate of lymph
node metastases and, consequently, to the ﬁnal prog-
nosis of affected patients.23 However, studies have
failed to show any expression of aSMA in potentially
malignant lesions of the oral cavity and in normal oral
mucosa, highlighting that myoﬁbroblasts appear to be
associated with molecular cross talk between stromal
elements and neoplastic epithelial cells.34-36 This is
further supported in the present study by the lack of
immunoreactivity in areas devoid of neoplastic islands.
In conclusion, although further studies would be
necessary for a better understanding of the biological
features of OSCC affecting young patients and the role
of myoﬁbroblasts in its development and behavior, the
results obtained in the current investigation suggest that
no signiﬁcant difference exists between the stromal
myoﬁbroblastic component of TSCC affecting young
and old individuals.REFERENCES
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